December 6, 2001 (download PDF)
Cypress Files IND to Begin Clinical Testing of Drug Candidate For Treatment of Fibromyalgia Syndrome

October 16, 2001 (download PDF)
Cypress Bioscience Names Lisa Walters-Hoffert Executive Vice President and CFO

August 13, 2001 (download PDF)
Cypress Bioscience Announces Second Quarter 2001 Results

August 1, 2001 (download PDF)
Cypress Bioscience In-Licenses bioMérieux Pierre Fabre Drug For Development in Fibromyalgia Treatment

July 27, 2001 (download PDF)
Cypress Bioscience Discussing Progress with Fibromyalgia Initiative at Annual Meeting

July 19, 2001 (download PDF)
Cypress Bioscience Announces Formation of Psychopharmacology Advisory Board for Fibromyalgia

July 11, 2001 (download PDF)
Cypress Bioscience Launches Genomic Research Program for Fibromyalgia

July 5, 2001 (download PDF)
Cypress Bioscience Names John N. Bonfiglio, Ph.D. as Executive Vice President and Chief Operating Officer

June 28, 2001 (download PDF)
Cypress Bioscience Appoints Sheldon Drobny to Board of Directors

June 25, 2001 (download PDF)
Cypress Bioscience Appoints Martin B. Keller, M.D., to Board of Directors

May 22, 2001 (download PDF)
Cypress Bioscience Announces Formation of New Scientific Advisory Board for Fibromyalgia Initiative

May 14, 2001 (download PDF)
Cypress Bioscience Announces First Quarter 2001 Results

April 4, 2001 (download PDF)
Cypress Bioscience, Inc. Appoints Charles B. Nemeroff, M.D. Ph.D. to Board of Directors. Building Team to Support New Fibromyalgia Program

April 2, 2001 (download PDF)
Cypress Bioscience and Georgetown University Form Alliance on Discovery and Development of Novel Treatments for Fibromyalgia Syndrome

March 9, 2001 (download PDF)
Cypress Bioscience Announces Fourth Quarter and Fiscal Year End 2000 Results

February 14, 2001 (download PDF)
Cypress Bioscience Announces Expansion of Agreement with Sanquin Blood Supply Foundation

January 22, 2001 (download PDF)
Cypress Bioscience Announces Restructuring of Prosorba Column Agreement with Fresenius